Real-Time lung cancer detection: new imaging technique could speed up diagnosis

NCT ID NCT07538947

Recruiting now Diagnosis Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a special microscope called confocal laser endomicroscopy (CLE) can help doctors identify non-small cell lung cancer in real time during a biopsy. About 70 adults with suspected lung tumors will undergo standard bronchoscopy with added CLE imaging. Researchers will compare the CLE images to standard lab results to see if the new method is accurate enough to guide immediate surgical decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: confocal laser endomicroscopy (CLE) imaging
What this could lead to: If successful, this could give doctors a real-time tool to identify lung cancer during a biopsy, leading to faster surgical decisions and fewer repeat procedures.
What could go wrong: This is a small, early observational study (70 people) testing a new scoring system. It may not prove accurate enough for routine use, and the technique requires special equipment and training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

CHRU Nancy
RECRUITING

Nancy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.